NIOSH Support for Conferences and Scientific Meetings (U13 Clinical Trial Not Allowed)

Go to Funding Search

Key Information

Due Date: December 14, 2025


Agency: U.S. Department of Health and Human Services (HHS)


Source: Federal


Funding Category:

Health & Human Services

Funding Amount: $581,371


Funding Type: Cooperative Agreement


Match Required: No


Status: Posted


Contact Info: FBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

Overview

The NIOSH Support for Conferences and Scientific Meetings (U13) is a grant that provides funding for high-quality scientific meetings, conferences, and workshops. This grant is specifically for events that align with NIOSH's scientific mission and core objectives, which include promoting occupational safety and health, furthering NIOSH program priorities, and enhancing public health.

As a crucial part of NIOSH's overall mission, the conference program aims to foster a space for discussions, learning, and progress within the field. For a grant application to be considered, it should contribute to and spur progress in key areas of research in occupational safety and health. Importantly, the research should align with interests of both NIOSH programs and the National Occupational Research Agenda. Furthermore, it should be noted that U13 Clinical Trials are not permitted under this grant.

Show More

Key Dates

Open Date: March 5, 2021


Application Due Date: December 14, 2025


Estimated Award Date: Not Specified

Additional Details

Eligible Activities

  • Research and Development

Eligible Applicants

  • State governments
  • County governments
  • City, village or township governments
  • Special district governments
  • Independent school districts
  • Public and State controlled institutions of higher education
  • Private institutions of higher education
  • Small businesses

Search MI Funding Hub

NOTE: Site search does not include grant search. See Find Funding page for grant searching.